03 B Cells
![](https://i.imgur.com/A2zyFOR.jpg)
BCR
![](https://i.imgur.com/1fwbEZG.jpg)
- FAB: fragment antigen binding
- FC: constant
- Made of monomer IgM antibody
![](https://i.imgur.com/dyO6NT8.jpg)
- purple: variable regions. Vary from 1 B cell to another
- light chain: 1 constant region; heavy chain 3 constant regions
- variable regions end in nitrogen groups; constant end in carboxyl group
- Connected by disulfide bridges
- macrophage Fc/protein A binds CH2-CH3 region
Heavy chain
![](https://i.imgur.com/y2z2gYH.jpg)
Activation
![](https://i.imgur.com/oxVfk7C.jpg)
![](https://i.imgur.com/4cfprgr.jpg)
- B cell crosslinked by antigen
- Second signal required in addition to crosslinking
- MHC 2 binds TCR and CD4
- CD40 binds CD40L: class switching
- B7 binds CD28: T cytokine secretion
![](https://i.imgur.com/i5b5QLG.jpg)
![](https://i.imgur.com/1JjQLH3.jpg)
- macrophage antigen presenting instead
T Independent
![](https://i.imgur.com/3akFi8f.jpg)
- so many antigen on surface, B cell activated without T
![](https://i.imgur.com/RrAh4pr.jpg)
Conjugated Vaccine
![](https://i.imgur.com/DA4OSvs.jpg)
![](https://i.imgur.com/ACgfNmh.jpg)
Surface Proteins
![](https://i.imgur.com/lujcvb1.jpg)
- CD21 receptor for complement, receptor for EBV
Antibody
![](https://i.imgur.com/RxxJjBn.jpg)
![](https://i.imgur.com/gCTQ0p5.jpg)
Protein A
![](https://i.imgur.com/lRLA8sB.jpg)
![](https://i.imgur.com/7sEsfpd.jpg)
Class Switching
![](https://i.imgur.com/KtWItuK.jpg)
- only change Fc portion, not FAB portion
![](https://i.imgur.com/XAy53KN.jpg)
- Cm and Cd closes
- Cm and Cd spliced out; B starts to make Cy (IgG), Ca, Ce
IgM
![](https://i.imgur.com/pBviPSN.jpg)
- Classical pathway: 2 C1 molecules bind together to Fc of IgM; easy to bind because so many IgM Fc together
- Prevents attachment: very large and clumps on to pathogens
- Weak opsonin: too big; macrophages can't get to Fc
IgG
![](https://i.imgur.com/bXte5WE.jpg)
- macrophages bind to Fc very easily
![](https://i.imgur.com/X1Hoj3l.jpg)
IgA
![](https://i.imgur.com/NhdPoTh.jpg)
- secretory component in middle of 2 IgA
- linked by secretory: can't complement
![](https://i.imgur.com/GRq5CQz.jpg)
![](https://i.imgur.com/e8DEvuP.jpg)
IgA Protease
![](https://i.imgur.com/BSs1OgZ.jpg)
IgE
![](https://i.imgur.com/1TGHjRn.jpg)
![](https://i.imgur.com/rRbRPff.jpg)
Somatic Hypermutation
![](https://i.imgur.com/11Zxg0l.jpg)
- Happens during proliferation after activation
- Stronger binding will proliferate the most
![](https://i.imgur.com/xNp1VUU.jpg)
B Cell Fate
![](https://i.imgur.com/lfbpZzH.jpg)
![](https://i.imgur.com/Kbraux3.jpg)
Development Timeline
![](https://i.imgur.com/gxWzpI1.jpg)
Vaccines
Active
![](https://i.imgur.com/o1HPdOJ.jpg)
![](https://i.imgur.com/qFfnmuH.jpg)
- Live attenuated: T cell mediated response
- Killed: antibodies against HA antigens of virus
- Inactivated viral vaccines do not infect host cells and therefore do not enter the MHC class I antigen-processing pathway, which is normally required for the generation of a significant CD8+ cell-mediated immune response. In contrast, live-attenuated viral vaccines strongly stimulate the MHC class I antigen-processing pathway and can generate cytotoxic CD8+ T lymphocytes that kill infected cells.
![](https://i.imgur.com/0riB2l8.jpg)
Passive
![](https://i.imgur.com/ozbdHnz.jpg)
- give if suspicion for rabies, tetanus: neutralize before infection happens
Backlinks